https://www.prnewswire.com/news-releases/moberg-pharma-and-taisho-sign-exclusive-license-agreement-for-mob-015-in-japan-300927822.html
Moberg Pharma and Taisho Sign Exclusive License Agreement for MOB-015 in Japan
/PRNewswire/ -- Moberg Pharma AB (OMX: MOB) has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd for development, registration and...
exclusive license agreement
https://www.businesswire.com/news/home/20211122006522/en/Arrowhead-Pharmaceuticals-Enters-Exclusive-License-Agreement-with-GSK-for-ARO-HSD
Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD
Arrowhead Pharmaceuticals and GlaxoSmithKline sign exclusive license agreement for RNAi candidate ARO-HSD against NASH
exclusive license agreementarrowhead pharmaceuticalsenters
https://www.prnewswire.com/news-releases/wize-pharma-enters-exclusive-license-agreement-for-ophthalmic-non-viral-gene-therapy-technology-300914052.html
Wize Pharma Enters Exclusive License Agreement for Ophthalmic Non-viral Gene Therapy Technology
/PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced...
exclusive license agreement
https://www.biospace.com/foresee-pharmaceuticals-enters-exclusive-license-agreement-with-gensci-for-the-commercialization-of-camcevi-tm-in-china
Foresee Pharmaceuticals Enters Exclusive License Agreement with GenSci for the Commercialization of...
Nov 17, 2020 - Foresee Pharmaceuticals announced that it has entered into an exclusive license agreement with GenScience Pharmaceuticals - a wholly-owned subsidiary of...
exclusive license agreement
https://www.prnewswire.com/news-releases/inmagene-and-kissei-enter-into-an-exclusive-license-agreement-for-fostamatinib-in-china-301345936.html
Inmagene and Kissei Enter into an Exclusive License Agreement for Fostamatinib in China
/PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") and Kissei Pharmaceutical Co., Ltd. ("Kissei") announced today that they have entered into an...
exclusive license agreement
https://www.gilead.com/news/news-details/2022/kite-and-refuge-biotechnologies-announce-exclusive-license-agreement-for-investigational-gene-expression-platform-for-blood-cancers
Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene...
Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene Expression Platform for Blood Cancers
exclusive license agreementkiterefugebiotechnologiesannounce
https://www.biospace.com/coeptis-therapeutics-adds-autoimmune-indications-to-exclusive-license-agreement-with-university-of-pittsburgh-for-snap-car-t-and-snap-car-nk
Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of...
Feb 26, 2024 - Coeptis Therapeutics Holdings, Inc. today announced that it has expanded its exclusive license agreement with the University of Pittsburgh to include...
exclusive license agreement
https://www.dlapiper.com/en-ca/news/2025/09/dla-piper-assisted-servier-in-the-negotiation-of-an-exclusive-license-agreement
DLA Piper advised Servier in its exclusive license agreement with IDEAYA Biosciences for...
DLA Piper assisted Servier, an international pharmaceutical group with headquarters in France, in the negotiation of an exclusive license agreement with IDEAYA...
exclusive license agreement
https://www.prnewswire.com/news-releases/jemincare-announces-exclusive-license-agreement-with-genentech-to-develop-and-commercialize-novel-oral-androgen-receptor-degrader-301608317.html
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel...
/PRNewswire/ -- Jemincare, a leading pharmaceutical company from China, announced today that it and its wholly owned subsidiary company, Shanghai Jemincare...
exclusive license agreement
https://www.biospace.com/compugen-to-host-conference-call-to-discuss-exclusive-license-agreement-with-gilead-for-com503-novel-immuno-oncology-pre-clinical-program-harnessing-il-18-biology
Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503,...
Dec 20, 2023 - Compugen Ltd. today announced that it will host a conference call at 8:30 AM ET today, to discuss the exclusive license agreement with Gilead announced today,...
exclusive license agreement
https://www.biospace.com/press-releases/earendil-labs-announces-worldwide-exclusive-license-agreement-with-sanofi-for-next-generation-bispecific-antibodies-for-autoimmune-and-inflammatory-bowel-diseases
Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation...
exclusive license agreement
https://www.biospace.com/press-releases/transpire-bio-enters-into-exclusive-license-agreement-with-suzhou-intragrand-pharma-for-investigational-pde4-inhibitor
Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for...
exclusive license agreement
https://www.biospace.com/degron-therapeutics-announces-multi-target-collaboration-and-exclusive-license-agreement-with-takeda-to-discover-molecular-glue-degraders
Degron Therapeutics Announces Multi-Target Collaboration and Exclusive License Agreement with...
Jul 17, 2024 - Degron Therapeutics, the company using its molecular glue-based targeted protein degradation drug-discovery platform to advance human health, announced it has...
exclusive license agreementdegrontherapeuticsannouncesmulti
https://www.prnewswire.co.uk/news-releases/foresee-pharmaceuticals-enters-exclusive-license-agreement-with-accord-healthcare-876861376.html
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
/PRNewswire/ -- An exclusive license agreement for the commercialisation of Foresee Pharmaceutical's (6576.TWO) novel FP-001 program (leuprorelin depot),...
exclusive license agreementforeseepharmaceuticalsentersaccord
https://www.merck.com/news/merck-enters-exclusive-worldwide-license-agreement-with-teijin-pharma-for-investigational-antibody-candidate-targeting-tau/
Merck Enters Exclusive Worldwide License Agreement with Teijin Pharma for Investigational Antibody...
May 11, 2026 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has entered into an exclusive worldwide license agreement with...
license agreement
https://www.businesswire.com/news/home/20240506079856/en/Xeris-Enters-Into-an-Exclusive-Worldwide-Collaboration-and-License-Agreement-with-Beta-Bionics
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commerciali...
https://www.globenewswire.com/fr/news-release/2025/06/24/3104106/18362/en/amarin-announces-exclusive-license-and-supply-agreement-with-recordati-to-commercialize-vazkepa-icosapent-ethyl-in-europe.html
Amarin Announces Exclusive License and Supply Agreement
-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive...
exclusive licenseamarinannouncessupplyagreement
https://www.lawinsider.com/contracts/tagged/non-exclusive-unlimited-pro-license-agreement
Non-Exclusive Unlimited Pro License Agreement Sample Contracts | Law Insider
Non-Exclusive Unlimited Pro License Agreement sample contracts and agreements.
non exclusivepro licensesample contractsunlimitedagreement
https://finviz.com/news/339567/2020-biolabs-announces-exclusive-us-license-agreement-with-rokit-healthcare-to-integrate-advanced-ckd-prediction-technology-into-its-longevity-test-program
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate...
Stock screener for investors and traders, financial visualizations.
https://www.biospace.com/press-releases/vor-bio-enters-into-exclusive-global-license-agreement-with-remegen-for-late-stage-autoimmune-asset
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset...
https://www.prnewswire.co.uk/news-releases/avecho-and-sandoz-enter-exclusive-license-and-development-agreement-to-commercialise-cbd-for-insomnia-in-australia-302390766.html
Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for...
Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for...
exclusive license
https://www.prnewswire.com/news-releases/cboe-and-gemini-enter-into-exclusive-global-license-agreement-to-use-bitcoin-market-data-300498072.html
CBOE and Gemini Enter Into Exclusive Global License Agreement to Use Bitcoin Market Data
/PRNewswire/ -- CBOE Holdings, Inc. (BATS: CBOE | NASDAQ: CBOE) and Gemini Trust Company, LLC (Gemini) today announced an agreement that provides Chicago...